News Releases

Xavier Ochsner College of Medicine earns preliminary accreditation

The only HBCU college of medicine in the Gulf South, the College of Medicine brings together two trusted New Orleans institutions: Xavier University of Louisiana and Ochsner Health. 

Loyola University New Orleans and Ochsner Health launch Executive MBA partnership

Participants are taking part in an intensive executive MBA experience that combines Loyola’s graduate business education with the real-world leadership challenges facing healthcare professionals and organizations today.

Ochsner Health and Paradigm Health expand access to clinical trials across the Gulf South

Ochsner implemented Paradigm Health's AI-powered patient recruitment platform, which integrates within electronic health records and other clinical data sources to continuously evaluate a patient’s medical record against clinical trial eligibility criteria. 

Ochsner Health Research Week showcases biomedical discovery and clinical trial innovation

Ochsner Children’s cardiologist named one of several principal investigators in $15 million initiative to treat heart valve disease

In collaboration with Cincinnati Children’s, Dr. Sable and Ochsner helped lead the development of the Strategic Hub for Interventions to Promote Early Detection and Lifelong Protection from Advanced Rheumatic Heart Disease (SHIELD) Center. 

Research by Ochsner experts explores making behavioral health care more accessible

A study published this month in the American Journal of Managed Care explores how integrating behavioral health care into primary care can improve outcomes and be cost-effective for adults with depression, anxiety and chronic pain who are on long-term opioid therapy.

The University of Queensland Medical School-Ochsner Health and Ochsner Graduate Medical Education celebrate high Match Day rates

This marks the fourteenth consecutive year that the UQ-Ochsner MD Program’s match rate has been 90% or above. Overall, more than 66% of the medical school’s graduates matched with their top three choices for residency, with 46% of our medical students placing with their first choice.

Ochsner research team reports safe and effective outcomes with emerging combination therapy for liver cancer

As an early adopter of combination treatments, the research team was able to provide an early experience regarding the safety and efficacy of combination treatments in advance of clinical trial results. 

83 doctors-in-training at the UQ-Ochsner MD program receive white coats

The University of Queensland Medical School – Ochsner Health (UQ-Ochsner MD) honored its doctors-in-training on Saturday, Jan. 10 at its 16th annual White Coat Ceremony, a rite of passage for medical students held to emphasize the importance of compassionate patient care from the start of medical training. 

Ochsner research leads groundbreaking findings for Multi-Cancer Early Detection (MCED)

Entitled “Real-world data and clinical experience from over 100,000 multi-cancer early detection tests,” the study was recently published in Nature Communications.